Absorbable Hemostatic Agent Downclassification Endorsed By Panel

Content review of FDA's planned special controls guidance was instrumental in the General & Plastic Surgery Devices Panel's July 24 recommendation that absorbable hemostatic agents be downclassified from Class III to Class II